Argonaute-2

Argonaute-2

Product Inquiry

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
NitisinoneSC-0735; SYN-118; NTBCApprovedSwedish Orphan Biovitrum AgOrfadin, NityrUnited StatesTyrosinemiasSwedish Orphan Biovitrum Ag2002-01-18
Alkaptonuria; Blindness; Tyrosinemias; Albinism
Details